StockTipsArenaBeta

BUY Ajanta Pharma Limited — Motilal Oswal

BUYAjanta Pharma Limited
Ajanta Pharma share price target & all analyst calls

byMotilal OswalHorizon: NA (inferred 1 year)30 Jul 2026via Moneycontrol Broker Research

Entry₹3,436.4Inferred
Target₹4,000
Total upside +16.40%
Stop lossNot given
CMP₹3,279.3Just now
Active-4.57%+21.98%upside left 9 mo left
Follow Motilal Oswal for new calls(62% target hit, 1108 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 2 other Long-term calls on AJANTPHARMSee 255 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 12:29 pm IST
15 supporting3 neutral4 opposing
Supports the BUY call (15)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·22 Oct · yesterday

Ajanta Pharma promoter releases pledge on 98,185 shares for loan repayment

NewsGoogle News·28 Sept · 4w ago

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·10 Aug · 2mo ago

Neutral / worth noting (3)

Q2 FY27 results scheduled — board meets 30 Oct 2026

BSE · Board Meeting·In 7 days

(opens in new tab)
Weighs against the BUY call (4)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Ajanta Pharma

All analyst calls on Ajanta Pharma

More from Motilal Oswal

Every call and its outcome